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Abstract. 
 
Peroxisomal proteins are synthesized on free
polysomes and then transported from the cytoplasm to
peroxisomes. This process is mediated by two short
well-deﬁned targeting signals in peroxisomal matrix
proteins, but a well-deﬁned targeting signal has not yet
been described for peroxisomal membrane proteins
(PMPs). One assumption in virtually all prior studies of
PMP targeting is that a given protein contains one, and
only one, distinct targeting signal. Here, we show that
the metabolite transporter PMP34, an integral PMP,
contains at least two nonoverlapping sets of targeting
information, either of which is sufﬁcient for insertion
into the peroxisome membrane. We also show that an-
other integral PMP, the peroxin PEX13, also contains
two independent sets of peroxisomal targeting informa-
tion. These results challenge a major assumption of
most PMP targeting studies. In addition, we demon-
strate that PEX19, a factor required for peroxisomal
membrane biogenesis, interacts with the two minimal
targeting regions of PMP34. Together, these results
raise the interesting possibility that PMP import may
require novel mechanisms to ensure the solubility of in-
tegral PMPs before their insertion in the peroxisome
membrane, and that PEX19 may play a central role in
this process.
Key words: peroxisome • organelle biogenesis •
PEX19 • targeting signal • PMP34
 
Introduction
 
Proteins that are directed to subcellular compartments
contain targeting information that specifies their final lo-
cation. Often a single class of amino acid sequences directs
a multitude of proteins to the same cellular compartment.
 
In the case of the peroxisome, targeting to the organ-
elle matrix occurs posttranslationally and is mediated by
two cis-acting sequences, the peroxisome-targeting signal
 
(PTS)
 
1
 
 1 (Gould et al., 1987, 1989b) and PTS2 (Swinkels et
al., 1991). Proteins containing these signals are directed to
the peroxisome upon binding the corresponding signal se-
quence receptors, PEX5 and PEX7, and are then imported
into the peroxisome matrix in an ATP-dependent manner
by a common matrix protein import machinery.
Less is known about the import of proteins destined for
insertion into the peroxisome membrane. Like matrix pro-
teins, integral peroxisomal membrane proteins (PMPs) are
synthesized on free polyribosomes and imported post-
translationally from the cytosol (Fujiki et al., 1984; Suzuki
et al., 1987; Diestelkotter and Just, 1993; Imanaka et al.,
1996), though their import does not require the hydrolysis
of ATP (Diestelkotter and Just, 1993). In addition, inte-
gral PMPs lack functional PTS1 or PTS2 signals, and their
import is independent of the PTS1 and PTS2 receptors
(Chang et al., 1999; Hettema et al., 2000). Integral PMPs
are therefore thought to be imported into peroxisomes by
a distinct targeting mechanism from that used by peroxiso-
mal matrix proteins.
 
Multiple studies have attempted to define the targeting
 
information in integral PMPs. These include studies of 
 
Can-
dida boidinii
 
 PMP47 (McCammon et al., 1994; Dyer et al.,
1996), PEX3 from 
 
Pichia pastoris
 
, 
 
Hansenula polymorpha
 
,
and humans (Baerends et al., 1996, 2000; Wiemer et al.,
1996; Kammerer et al., 1998; Soukupova et al., 1999), 
 
P. pas-
toris
 
 PEX2, PEX10, PEX13, PEX17, and PEX22 (Snyder et
al., 2000), rat PMP22 (Pause et al., 2000), and human
 
PMP70 and PEX11
 
 
 
 (Sacksteder et al., 2000). Of these stud-
ies, only the examination of 
 
C
 
.
 
 boidinii 
 
PMP47 defined PMP
targeting information at the level of functional residues. In
that study, Dyer et al. (1996) reported that the PMP47 tar-
geting information lies between transmembrane domains 4
and 5 in a positively charged intraperoxisomal loop. Al-
though these studies have all advanced our understanding of
PMP targeting, they have not yet yielded a clear model of
what constitutes a PMP targeting signal. In addition, virtu-
ally all of the above studies have assumed that PMPs con-
tain one and only one set of targeting information.
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Here, we report an examination of the targeting infor-
mation in PMP34, the human homologue of 
 
C
 
.
 
 boidinii
 
PMP47. We demonstrate that PMP34 contains not one but
at least two targeting signals, either of which is sufficient
for targeting to peroxisomes. We also show that two non-
overlapping segments of PEX13 target to peroxisomes, in-
dicating that the presence of multiple independent target-
ing regions within a single PMP is not unique to PMP34.
Last, we demonstrate that the minimal targeting regions of
PMP34 both bind to PEX19. The implications of these re-
sults for PMP recognition and targeting are discussed.
 
Materials and Methods
 
Plasmids
 
The plasmids pcDNA3-PMP34myc and pcDNA3-PEX13myc have been
described (Liu et al., 1999; Sacksteder et al., 2000). All PMP34 and PEX13
truncation mutants were generated by amplifying the desired fragment us-
ing primers that append the sequence 5
 
 
 
-GGTACCATG-3
 
 
 
 (encoding an
Asp718 site and a start codon) at the 5
 
 
 
 end of the fragment, and the se-
quence 5
 
 
 
-GGATCC-3
 
 
 
 (encoding a BamHI site) at the 3
 
 
 
 end of the frag-
ment, using the published sequences as a guide (Bjorkman et al., 1998;
Wylin et al., 1999). PCR products were then digested with Asp718 and
BamHI and cloned upstream of, and in frame with, either 3 sequential
c-
 
myc
 
 epitopes in the plasmid pcDNA3/3xmyc (Geisbrecht et al., 1998) or
13 sequential c-
 
myc
 
 epitopes in the plasmid pcDNA3/13xmyc. The plas-
mid pNHA is designed to append a 17–amino acid hemagglutinin (HA)
epitope tag, NH
 
3
 
-MAYPYDVPDYAGGSGSS-COOH, to the NH
 
2
 
 termi-
nus of a protein. The expression vector pNHA-PTE1 was constructed by
inserting a BamHI/XbaI fragment of pNmyc-
 
PTE1
 
 (Jones et al., 1999),
containing the 
 
PTE1
 
 ORF, into the BamHI and XbaI sites of pNHA. The
plasmid pNHA-
 
PEX19
 
 was made by excising the 
 
PEX19
 
 ORF from
pT7
 
his6
 
-
 
PEX19
 
 (Sacksteder et al., 2000) by digestion with SalI and NotI
and inserting it into the XhoI and NotI sites of pNHA. The p3xNLS vec-
tor is designed to append three contiguous copies of the viral SV-40 T an-
tigen nuclear localization signal (Adam and Gerace, 1991), in the form of
the amino acid sequence NH
 
3
 
-MACPKKKRKVGDGGCPKKKRK-
VGDGGCPKKKRKVGDGS-COOH, to the NH
 
2
 
 terminus of a protein.
To construct the p3xNLS vector, a PCR product was generated that en-
coded the above amino acid sequence and contained HindIII and BamHI
sites at its 5
 
 
 
 and 3
 
 
 
 ends, respectively. The PCR product was then digested
with HindIII and BamHI and inserted into the HindIII and BamHI sites
of pNmyc-
 
PTE1
 
 to make p3xNLS-
 
PTE1
 
, effectively exchanging the
3xNLS sequence for the c-
 
myc
 
 epitope tag. The plasmids p3xNLS-
 
PEX19
 
and p3xNLS-
 
HAOX3
 
 were made by excision of the appropriate ORF
from pT7
 
his6
 
-
 
PEX19
 
 or pT7
 
his6
 
-
 
HAOX3
 
 by digestion with SalI and NotI
and inserting them into the XhoI and NotI sites of p3xNLS-
 
PTE1
 
, effec-
tively swapping the 
 
PEX19
 
 or 
 
HAOX3
 
 ORFs for that of 
 
PTE1
 
. All clones
generated by PCR amplification were sequenced to ensure the absence of
any unintended mutations.
 
Indirect Immunofluorescence and Fluorescence Microscopy
 
Indirect immunofluorescence studies were performed on normal human
skin fibroblasts (GM 5756-T) or the 
 
PEX10
 
-deficient fibroblast cell line,
PBD100, which has been described previously (Warren et al., 1998). Cell
lines were cultured and transfected as described (Chang et al., 1997). After
transfection, cells were transferred to cover glasses and incubated in com-
plete medium for 1 d. The cells were then fixed in 3% formaldehyde, per-
meabilized with 1% Triton X-100, and processed for indirect immunofluo-
rescence as described (Chang et al., 1997). The anti–c-
 
myc
 
 mouse
monoclonal antibody was derived from tissue culture medium of the
mouse hybridoma line 1-9E10 (Roche Molecular Biochemicals). Sheep
anti-PMP70 and rabbit anti-PEX19 antibodies (Sacksteder et al., 2000) and
rabbit anti-HAOX3 antibodies (Jones et al., 2000) have been described.
Fluorescent secondary antibodies were obtained from commercial sources.
 
Cell Lysates, Na
 
2
 
CO
 
3
 
 Extraction, Immunoprecipitation, 
and Immunoblots
 
Normal human skin fibroblasts (GM5756-T) or 
 
PEX10
 
-deficient PBD100
fibroblasts were cultured and transfected with the appropriate expression
plasmids as described (Chang et al., 1997). 1 d after transfection, cells
were washed twice in PBS (GIBCO BRL) and harvested by gentle scrap-
ing. For whole cell lysates, transfected cells were briskly resuspended in
PBS plus 1% Triton X-100. Protein content of lysates was determined us-
ing the Bio-Rad protein assay (Bio-Rad Laboratories). Equal quantities
of total protein from each lysate were separated by PAGE, transferred to
membranes, and analyzed by immunoblot using standard protocols
(Crane et al., 1994).
For membrane extraction experiments, cells were resuspended in hypo-
tonic lysis buffer (10 mM Tris HCl, pH 7.5, 1 mM EDTA, Complete™
protease inhibitor cocktail [Boerhinger]) and lysis was achieved by pass-
ing cell slurries through a 20-gauge syringe needle five times. Cellular
membranes were harvested by centrifugation at 100,000 
 
g
 
 for 1 h. Super-
natant and pellet were separated, pellets were resuspended in 100 mM
Na
 
2
 
CO
 
3
 
 at a final protein concentration of 0.4 mg/ml, and the suspensions
were incubated for 30 min on ice with gentle agitation. Membranes were
pelleted by centrifugation at 100,000 
 
g
 
 for 1 h. Extraction samples were di-
luted to the initial volume of lysate, and equal volumes of the samples
were analyzed by immunoblot using standard techniques (Crane et al.,
1994). Detection of the c-
 
myc
 
 epitope was performed by a commercially
available anti–c-
 
myc
 
 polyclonal antibody (Santa Cruz Biotechnology,
Inc.), and detection of catalase was performed by a commercially avail-
able sheep anticatalase antibody (The Binding Site). Anti-PEX13 anti-
bodies were raised in rabbit against a synthetic peptide corresponding to
the COOH-terminal 14 amino acids of human PEX13 (Gould et al., 1996).
For immunoprecipitation experiments, cells expressing either
PMP34aa1-147/13xmyc or PMP34aa244-307/3xmyc in combination with
either HA-PEX19 or HA-PTE1 were lysed in 500 
 
 
 
l hypotonic lysis
buffer as above. Lysates were then subjected to centrifugation at 25,000 
 
g
 
for 15 min to pellet large organelles such as peroxisomes. The resulting su-
pernatant was brought to 1 ml final volume by addition of PBS (Life Tech-
nologies) plus Complete™ protease inhibitor cocktail (Boehringer). 20 
 
 
 
l
of a 50% slurry of protein A agarose (Sigma-Aldrich) in PBS was added
and the mixture, incubated with mixing at 4
 
 
 
C for 30 min. The protein A
agarose was pelleted, and the supernatant was removed to a new tube. 15
 
 
 
l of a 50% slurry of anti-HA monoclonal antibodies coupled to agarose
beads (Santa Cruz Biotechnology, Inc.), which had been preincubated in
0.1 mg/ml BSA in PBS for 30 min, was added to each sample, and the mix-
tures were incubated with mixing at 4
 
 
 
C for 3 h. The anti-HA beads were
recovered by centrifugation, washed 4 times with 1 mL PBS, and resus-
pended in SDS-PAGE sample buffer. Corresponding proportions of ly-
sate and immunoprecipitate samples were analyzed by immunoblot using
the anti–c-
 
myc
 
 polyclonal antibody as above.
 
Results
 
Epitope-tagged PMP34 Localizes to Peroxisomes
 
C. boidinii
 
 PMP47 was the subject of the first detailed ex-
amination of PMP targeting signals (Dyer et al., 1996). We
felt that its human homologue (Wylin et al., 1999) would
therefore be a useful model protein for the study of target-
ing information in mammalian PMPs. We proceeded to
search for targeting information in this protein using the
same experimental system that was used to identify the
peroxisomal matrix protein targeting signals PTS1 and
PTS2 (Gould et al., 1989a; Swinkels et al., 1991). Specifi-
cally, we designed genes to express a set of mutant PMP34
proteins, expressed those genes in mammalian cells by
transient transfection, and assessed the distribution of
their products by indirect immunofluorescence.
To distinguish between endogenously expressed PMP34
and PMP34 proteins expressed from plasmids, the plas-
mid-encoded proteins all contained the c-
 
myc
 
 epitope at
their COOH terminus. The full-length PMP34myc fusion
protein was expressed in wild-type human fibroblasts (Fig.
1 a) and was efficiently targeted to peroxisomes (b and c).
The Zellweger syndrome fibroblast cell line PBD100 is un-
able to import peroxisomal matrix proteins but imports
PMPs normally (Warren et al., 1998). PMP34myc was ex- 
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pressed in PBD100 cells (Fig. 1 a) and was targeted to per-
oxisomes (d and e), demonstrating that PMP34myc is tar-
geted to peroxisomes by a membrane protein targeting
pathway, as previously suggested (Wylin et al., 1999).
 
PMP34 Contains Multiple Peroxisomal Targeting Signals
 
One strategy for identifying targeting information in a
protein is to identify mutations that disrupt its targeting
and then deduce the necessary targeting information from
the positions of the mutations. However, this method is
unreliable since protein import can be disrupted by im-
proper folding, insolubility, or instability of a protein
rather than a specific defect in a protein’s targeting infor-
mation. For example, mutations that disrupted the peroxi-
some targeting of luciferase were very misleading in the
search for the PTS1 (Gould et al., 1987). Another strategy
is to identify the minimal region(s) of a protein that are
sufficient for its proper subcellular localization. This
method is less sensitive to artifacts and was, in fact, the ap-
proach used to identify both the PTS1 (Gould et al.,
1989a) and PTS2 (Swinkels et al., 1991). Therefore, we
proceeded to scan PMP34 for regions that were sufficient
for peroxisomal targeting (Fig. 2).
We first made a series of deletions starting at the
COOH terminus of the protein and found that the NH
 
2
 
-
terminal 147 amino acids were capable of targeting to per-
oxisomes (Fig. 3, a and b). Truncation mutants shorter
than this either failed to express in multiple trials or did
not target to peroxisomes. Next, we made a series of trun-
cations beginning from the NH
 
2
 
 terminus and found that
the COOH-terminal 64 amino acids of PMP34 retained
excellent targeting to peroxisomes (Fig. 3, c and d). In
 
these studies, PMP34 truncations that targeted to peroxi-
somes but no other compartments were designated 
 
   
 
,
those that targeted to peroxisomes and targeted to other
compartments in some cells were designated 
 
  
 
, those
that targeted to peroxisomes and targeted to other com-
partments in all cells were designated 
 
 
 
, and those that
showed no peroxisomal targeting were designated 
 
 
 
. Most
other studies of PMP targeting information have assumed
that each PMP contains a single targeting signal (Baerends
et al., 1996, 2000; Wiemer et al., 1996; Kammerer et al.,
1998; Pause et al., 2000; Snyder et al., 2000), including
some from our own laboratory (Sacksteder et al., 2000).
Thus, the identification of two discrete targeting signals in
PMP34 was entirely unexpected.
Next, we made small deletions in the NH
 
2
 
- and COOH-
terminal targeting regions. These attempts failed to iden-
tify smaller targeting segments of the NH
 
2
 
-terminal re-
gion. However, we did identify a smaller region at the
COOH terminus of PMP34 that retained targeting ability.
Specifically, we found that amino acids 255–307 of PMP34
targeted to peroxisomes with good efficiency, whereas a
construct containing amino acids 270–307 failed to target.
Dyer et al. (1996) and others (Baerends et al., 2000; Pause
et al., 2000) have emphasized the importance of basic
amino acids in PMP targeting signals, and there was a
patch of basic residues, HQRVRR, within the COOH-ter-
minal targeting region of PMP34 (amino acids 255–260).
However, we found that a smaller protein (amino acids
260–307) that lacked this patch of basic residues still tar-
geted to peroxisomes, albeit at reduced efficiency. Al-
though small truncations from the COOH terminus of this
region (constructs ending at amino acid 303 or 291) re-
Figure 1. PMP34myc localizes to peroxisomes
by a pathway distinct from that used by matrix
proteins. (a) Lysates of mock-transfected human
fibroblasts, fibroblasts expressing PMP34myc,
and PEX10-deficient PBD100 fibroblasts express-
ing PMP34myc were analyzed by immunoblot us-
ing anti-myc and anticatalase antibodies. (b–e)
Human skin fibroblasts expressing PMP34myc
were processed for double indirect immunofluo-
rescence by fixing cells and permeabilizing them
with 1% Triton X-100. The distribution of
PMP34myc was examined using anti-myc anti-
bodies (b) and anti-PMP70 antibodies (c). The
distribution of PMP34myc was also examined in
fibroblasts of the PEX10-deficient cell line
PBD100, again by double indirect immunofluo-
rescence using anti-myc antibodies (d) and anti-
PMP70 antibodies (e). Bar, 15  m. 
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duced the efficiency of targeting, they did not disrupt tar-
geting completely, suggesting that the extreme COOH
terminus of PMP34 did not contain essential targeting in-
formation. Comparison of the NH
 
2
 
- and COOH-terminal
minimal targeting regions did not identify a common se-
quence motif but did reveal that both regions contained a
putative membrane spanning domain.
Dyer et al. (1996) found that the peroxisomal targeting
signal of 
 
C
 
.
 
 boidinii
 
 PMP47 resided in the loop between
transmembrane spans 4 and 5. To determine whether the
corresponding loop in human PMP34 (Fig. 2, *) is also im-
portant for targeting to peroxisomes, we assayed the tar-
geting ability of several proteins containing this region. Al-
though the loop alone (amino acids 183–199) failed to
express to levels detectable by immunofluorescence, we
found that two larger constructs containing this segment
(amino acids 183–225 and amino acids 183–243) failed to
target to peroxisomes.
 
The Minimal Targeting Regions in PMP34 Are 
Sufficient for Membrane Insertion
 
Peroxisomal localization of the two PMP34 fragments
could reflect insertion into the peroxisome membrane.
However, it could also have been caused by interaction
with a binding partner at the peroxisome surface or by
cryptic import into the peroxisome matrix. To address
these concerns, fibroblasts expressing the NH
 
2
 
- and
COOH-terminal targeting elements of PMP34 were lysed
in hypotonic buffer. Soluble proteins were separated from
membranes by centrifugation, the membranes were ex-
tracted with alkaline sodium carbonate, and the resulting
suspension was separated into a membrane pellet and a
soluble supernatant. These fractions were then assayed by
immunoblot. Proteins containing either the NH
 
2
 
-terminal
PTS (PMP34aa1-147/3xmyc) or the COOH-terminal PTS
(PMP34aa244-307/3xmyc) remained in the membrane
even after carbonate extraction, demonstrating that these
signals direct proteins into the peroxisome membrane
(Fig. 4). As expected, control immunoblots showed that
the peroxisomal matrix enzyme catalase was released to
the supernatant by hypotonic lysis and that the integral
PMP PEX13 was resistant to carbonate extraction.
 
PEX13 Also Contains Multiple Independent
Targeting Signals
 
The presence of two distinct targeting signals in a single
PMP was unexpected and challenges the assumption that
only one targeting signal exists in a given PMP.  To deter-
Figure 2. Peroxisomal targeting of PMP34 mutants. Human
skin fibroblasts expressing a series of PMP34 mutants were ana-
lyzed by double indirect immunofluorescence using anti-myc an-
tibodies and antibodies to the peroxisomal marker protein
PMP70. Peroxisomal targeting of the mutants was scored as fol-
lows:     , peroxisomal targeting with no targeting to other
structures;   , peroxisomal targeting with some cells showing
staining of other compartments;  , peroxisomal targeting with all
cells also showing staining of other compartments;  , no peroxi-
somal targeting. DNE, did not express.
Figure 3. Two distinct regions of PMP34 are
sufficient for peroxisomal targeting. Human skin
fibroblasts expressing PMP34aa1–147/3xmyc (a
and b) or PMP34aa244–307/3xmyc (c and d)
were processed for double indirect immunofluo-
rescence by fixing cells and permeabilizing with
Triton X-100. The distribution of each PMP34
mutant was examined using anti-myc antibodies
(a and c) and antibodies to the peroxisomal
marker protein PMP70 (b and d). Bar, 15  m. 
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mine whether the presence of multiple PTSs was a unique
feature of PMP34 or might also occur in other PMPs, we
examined the targeting information in another integral
PMP, human PEX13.  Full-length PEX13 was efficiently
targeted to peroxisomes, as expected (Fig. 5, a and b).  A
fragment of PEX13 containing only amino acids 1–193 tar-
geted to peroxisomes (Fig. 5, c and d), as did a fragment
containing only amino acids 194–403 (e and f), although
this COOH-terminal fragment of PEX13 was also de-
tected in a perinuclear structure.  Thus, PMP34 is not the
only integral PMP that contains multiple, nonoverlapping
targeting signals.
 
Interaction of PEX19 with Targeting Signals from PMP34
 
In humans, PEX19 is required for the import of PMPs and
the synthesis of peroxisome membranes (Sacksteder et al.,
2000). We previously established that human PEX19 is a
predominantly cytoplasmic, partly peroxisomal protein
and interacts with 12 different PMPs and the targeting sig-
nals of at least two PMPs, PMP70 and PEX11
 
  
 
(Sack-
steder et al., 2000). Furthermore, we showed that mislocal-
ization of PEX19 to the nucleus results in the misdirection
of newly synthesized PMPs to the nucleoplasm rather than
the peroxisome membrane. Based on these and other re-
sults, we proposed that PEX19 might function as a PMP-
specific chaperone, an import receptor for newly synthe-
sized PMPs, or both.
We used the nuclear mislocalization assay to determine
whether PEX19 might also interact with the two targeting
signals of PMP34. A mutant version of the 
 
PEX19
 
 cDNA
was constructed that encoded three tandem copies of the
 
nuclear localization signal (NLS) from SV-40 large T anti-
gen (Adam and Gerace, 1991) at the 5
 
 
 
 end of the 
 
PEX19
 
ORF. The two small targeting elements of PMP34,
PMP34aa1-147/3xmyc, and PMP34aa244-307/3xmyc were
coexpressed with 3xNLS-PEX19 in normal human fibro-
blasts, and their subcellular distribution was determined
by immunofluorescence microscopy. Both fragments of
PMP34 were efficiently targeted to the nucleoplasm when
coexpressed with 3xNLS-PEX19 (Fig. 6, a–d). In contrast,
coexpression of these PMP34 fragments with a control
protein, 3xNLS-HAOX3, had no effect on their trafficking
to peroxisomes (Fig. 6, e–h; HAOX3 is a peroxisomal oxi-
dase that is not normally expressed in fibroblasts and is
not involved in PMP import [Jones et al., 2000]).
Next, we used coimmunoprecipitation as an inde-
pendent test of whether PEX19 can interact with the
smaller of the PMP34 targeting signals. Human fibroblasts
were cotransfected with plasmids designed to express (i)
PMP34aa1-147/13xmyc or PMP34aa244-307/3xmyc and
(ii) either an HA-tagged form of PEX19 or an HA-tagged
form of PTE1, a peroxisomal matrix enzyme not involved
in PMP import (Jones et al., 1999). Lysates were prepared
from the two cell populations and then processed for im-
munoprecipitation using anti-HA monoclonal antibodies.
The resulting immunoprecipitates were separated by SDS-
PAGE and blotted with anti-myc antibodies (Fig. 7). Both
PMP34aa1-147/13xmyc and PMP34aa244-307/3xmyc were
coimmunoprecipitated with HA-PEX19 but not HA-
PTE1, supporting the hypothesis that PEX19 interacts
with PMP targeting signals.
 
Discussion
 
Our data on PMP34 targeting raise three general ques-
tions. First, what is the nature of PMP targeting signals?
Second, why is it that some PMPs have multiple nonover-
lapping PMP targeting signals? Third, does PEX19 inter-
act with the PMP targeting signals identified in PMP34?
 
Properties of the PMP34 Targeting Signals
 
The two PTSs we identified correspond to amino acids
1–147 and 244–307 of PMP34. An inspection of these se-
quences failed to reveal any common sequences with each
other or with previously identified PTSs from human
PMP70 (Sacksteder et al., 2000), human PEX11
 
  
 
(Sack-
steder et al., 2000), human PEX14 (Sacksteder et al.,
2000), human PEX3 (Kammerer et al., 1998; Soukupova et
al., 1999), rat PMP22 (Pause et al., 2000), or PTSs identi-
fied in fungal forms of PMPs (Baerends et al., 1996, 2000;
Wiemer et al., 1996; Dyer et al., 1996; Snyder et al., 2000).
This was not altogether surprising, given that these previ-
ously described PMP targeting signals lack significant se-
quence similarities. We have also considered the possibil-
ity that there may be multiple types of PMP targeting
signals, just as there are at least two types of peroxisomal
matrix protein targeting signals. However, our efforts to
identify subgroups of PMP targeting signals that share
conserved sequence motifs have also failed.
Although PMP targeting signals lack recognizable amino
acid sequence motifs, they do have some common features.
One is that they are relatively long. A targeting signal in hu-
Figure 4. The two minimal targeting regions of PMP34 are in-
serted into the peroxisomal membrane. Human skin fibroblasts
expressing PMP34aa1–147/3xmyc or PMP34aa244–307/3xmyc
were lysed by thorough mixing in hypotonic buffer. Membranes
were pelleted by centrifugation, separated from the supernatant,
and incubated in alkaline sodium phosphate buffer. Membranes
were then pelleted again, separated from the supernatant, and re-
suspended. All fractions were diluted to the initial volume of
whole lysate. Equal volumes of each fraction were then assayed
by immunoblot using antibodies against the c-myc epitope, the
soluble peroxisomal matrix enzyme catalase, and the integral
PMP PEX13. 
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Figure 5. Two nonoverlapping regions of
PEX13 are sufficient for peroxisomal targeting.
Normal human fibroblasts expressing either
PEX13myc (a and b), PEX13aa1–193/3xmyc (c
and d), or PEX13aa194–403/3xmyc (e and f)
were analyzed by double indirect immunofluo-
rescence using anti-myc antibodies (a, c, and e),
or antibodies to the peroxisomal marker protein
PMP70 (b, d, and f). Bar, 15  m.
 
man PMP70 is 61 amino acids long (Sacksteder and Gould,
2000), a targeting signal from PEX11
 
 
 
 is 47 amino acids
long (Sacksteder and Gould, 2000), a targeting signal in rat
PMP22 is 97 amino acids long (Pause et al., 2000), and the
targeting signals we identified in human PMP34 are 147 and
64 amino acids long. In fact, the shortest PMP targeting sig-
nals yet identified are the first 33 amino acids of PEX3,
which functions only inefficiently (Soukupova et al., 1999),
and the first 25 amino acids of 
 
P
 
.
 
 pastoris
 
 PEX17 (Snyder et
al., 2000). The long length of PMP targeting signals con-
trasts sharply with the small size of the targeting signals for
peroxisomal matrix proteins, the PTS1 and PTS2, which are
three and nine amino acids long, respectively (Gould et al.,
1987, 1989b; Swinkels et al., 1991). This difference in target-
ing signal size may reflect the nature of protein targeting as-
says and the fundamental differences between membrane
and matrix protein targeting mechanisms. All protein tar-
geting assays measure two processes, the targeting of the
protein to its destination and the retention of the protein at
its destination. In the case of peroxisomal matrix protein
targeting, retention is provided by the passive barrier of the
peroxisome membrane and the targeting signals corre-
spond to the minimal sequence necessary for binding the
PTS1 and PTS2 receptors, PEX5 and PEX7 (Rehling et al.,
1996; Zhang and Lazarow, 1996; Gatto et al., 2000). How-
ever, the only retention mechanism for PMPs is insertion
into the peroxisomal membrane. PMP insertion likely re-
quires a transmembrane domain on the targeted protein,
but additional sequences may also be required for the inser-
tion process. Thus, it is not surprising that the second com-
mon property of PMP targeting signals is that they contain
at least one membrane-spanning domain.
Another feature of the PMP34 targeting signals that
warrants discussion is their relationship to the mPTS of
PMP47. PMP47 was the subject of the first PMP targeting
signal studies (McCammon et al., 1994; Dyer et al., 1996),
which concluded that its targeting signal, the mPTS, re-
sided within a hydrophilic loop between membrane span-
ning domains 4 and 5 (Dyer et al., 1996). We assumed that
the targeting signal of human PMP34 would be similar,
particularly since this loop is relatively well conserved be-
tween human PMP34 and 
 
C
 
.
 
 boidinii
 
 PMP47 (Wylin et al.,
1999). This is not the case. The two PTSs we identified in
human PMP34 differ in many respects from the mPTS of
 
C
 
.
 
 boidinii
 
 PMP47. The most obvious differences are that
the two targeting signals of human PMP34 do not corre-
spond in position or sequence to the mPTS of PMP47.
Also, the region of human PMP34 that does correspond to
the mPTS of PMP47 does not function as a PMP targeting
signal. Another notable difference is that the PMP34 tar-
geting signals both contain at least one putative mem-
brane-spanning domain, whereas the mPTS of PMP47
lacks a membrane-spanning domain. Another difference
worth discussing is the role of a basic patch of amino acids
in PMP targeting. A basic patch of amino acids was
thought to be important for the mPTS of PMP47 (Dyer et
al., 1996), and much attention has been given to the impor-
tance of basic amino acid patches in targeting of other
PMPs (Baerends et al., 2000; Pause et al., 2000). We iden-
tified a small patch of basic amino acids (amino acids 255–
259) in the COOH-terminal PMP34 targeting signal. How-
ever, a smaller fragment of PMP34 lacking these basic
residues (PMP34aa260–307/3xmyc) retained peroxisomal
targeting, indicating that a basic patch of amino acids may 
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not be an essential feature of all PMP targeting signals.
While this work was in progress, Wang et al. (2001) revis-
ited the peroxisomal targeting of 
 
C. boidinii PMP47 and
found that PMP47 does require a transmembrane domain
for targeting and that multiple fragments containing the
mPTS identified by Dyer et al. (1996) did not target to per-
oxisomes.  Furthermore, additional sequences far upstream
of the mPTS facilitated peroxisomal targeting of PMP47,
though there is as yet no data on whether PMP47 contains
more than one functional peroxisomal targeting signal.
While our study was in progress, an independent study
of PMP34 targeting information was reported by Honsho
and Fujiki (2001). However, their report concluded that at
least three transmembrane domains were necessary for
targeting, that PMP34 contained a single targeting signal,
and that the loop between transmembrane domains 4 and
5 of PMP34 was essential for targeting. Given that our
study and the Honsho and Fujiki study (2001) both exam-
ined the same protein (human PMP34) using a very similar
protein targeting assay in very similar cells, we feel
compelled to address the significant differences between
the two studies. Although there are some differences in
the experimental results, the major difference between the
two reports is in the interpretation of the data. Our conclu-
sions are drawn entirely from PMP34 fragments that tar-
get to peroxisomes. In contrast, Honsho and Fujiki based
many of their conclusions on PMP34 fragments that failed
to be targeted. For example, Honsho and Fujiki concluded
that the NH2-terminal half of PMP34 lacks targeting infor-
mation because a single fusion protein containing amino
acids 1–186 of PMP34 did not localize to peroxisomes,
whereas we showed that even smaller NH2-terminal frag-
ments did target to peroxisomes. Their conclusion ignores
other reasonable explanations, such as aggregation, insol-
ubility, or the masking of protein targeting signals in the
artificial fusion protein. Given the many possible reasons
that a mutant form of a protein might fail to target, we feel
that there is a logical basis for relying on positive experi-
mental results in the interpretation of these types of exper-
iments, and prior studies of the PTS1 support this view
(Gould et al., 1987).
Why Do Some PMPs Have Multiple Targeting Signals?
Previous studies of PMP targeting, including ours, have as-
sumed that there is one and only one targeting signal per
PMP (Baerends et al., 1996, 2000; Dyer et al., 1996; Kam-
Figure 6. PEX19 controls the subcellular distri-
bution of the PMP34 targeting elements.
PMP34aa1–147/3xmyc (a, b, e, and f) or
PMP34aa244–307/3xmyc (c, d, g, and h) were
transiently expressed in normal human fibro-
blasts in combination with either 3xNLS-PEX19
(a–d) or 3xNLS-HAOX3 (e–h). The distribu-
tions of the PMP34 fragments were determined
using antibodies to the c-myc epitope (left), and
the distributions of 3xNLS-PEX19 and 3xNLS-
HAOX3 were determined using antibodies to
PEX19 and HAOX3, respectively (right).The Journal of Cell Biology, Volume 153, 2001 1148
merer et al., 1998; Pause et al., 2000; Sacksteder et al.,
2000; Snyder et al., 2000). Our data show that this assump-
tion is flawed. We detected two distinct PTSs in
PMP34 and showed that two nonoverlapping fragments of
PEX13, another integral PMP, are targeted to peroxi-
somes. PMP70 also appears to have multiple targeting
signals; we have identified a PTS at the protein’s NH2 ter-
minus (amino acids 1–61 [Sacksteder et al., 2000]), and
Imanaka et al. (1996) demonstrated that another PTS
exists  in a COOH-terminal 50-kD fragment of PMP70.
Because these targeting signals are sufficient to direct
proteins to and into the peroxisome membrane, the identi-
fication of multiple targeting signals in several PMPs war-
rants further discussion.
We can envision two general hypotheses that might ex-
plain our observations. One is that the presence of multi-
ple targeting signals in PMP34, PEX13, and PMP70 re-
flects a random meaningless event, namely the unselected
acquisition of a second set of targeting information in
these proteins. This hypothesis suggests that all or most
other PMPs will be found to have one and only one PMP
targeting signal and that our results do not reveal anything
significant about the mechanism of PMP import. Although
we cannot exclude this possibility, it seems unlikely that
multiple proteins would acquire and maintain superfluous
targeting information. Thus, we must also consider the al-
ternative hypothesis that the presence of multiple peroxi-
somal targeting signals in PMP34, PEX13, and PMP70 is
meaningful and reflects the properties of the underlying
PMP import mechanism. But what mechanism would re-
quire multiple targeting signals per PMP?
Current paradigms of protein import systems do not pro-
vide an obvious answer to this question. Both co- and post-
translation import systems are known that rely on a single
set of targeting information. In addition, import mecha-
nisms that are heavily reliant on maintaining import sub-
strates in the unfolded state, such as translocation through
the endoplasmic reticulum and mitochondrial membranes
(Deshaies et al., 1988), are mediated by a single set of tar-
geting information, as is peroxisomal matrix protein im-
port, which appears to be less reliant on protein unfolding
before import (Subramani, 1993). In fact, there is only one
substantive difference we can see between existing para-
digms of protein import and PMP import. PMP import in-
volves the posttranslational import of proteins that contain
membrane-spanning domains (Lazarow and Fujiki, 1985).
It is generally appreciated that hydrophobic membrane-
spanning domains cannot be exposed to the aqueous envi-
ronment of the cytoplasm without deleterious affects on
protein folding and solubility. Thus, it may well be that
posttranslational import of PMPs requires special mecha-
nisms to prevent exposure of their transmembrane do-
mains to the cytoplasm. This could be accomplished by a
specific protein or protein complex that binds hydropho-
bic regions of PMPs during and/or after PMP synthesis
and before insertion of the PMP into the peroxisome
membrane. Furthermore, PMPs with multiple transmem-
brane domains such as PMP34, PEX13, and PMP70 might
be expected to contain multiple sites for interaction with
such a PMP binding factor.
A priori, the existence of such a PMP binding factor
does not demand the presence of multiple targeting signals
in a polytopic PMP. However, we can imagine one circum-
stance in which it would. If the interaction between a PMP
and the PMP binding factor is sufficient to direct the PMP
into the peroxisomal import pathway, then we would ex-
pect that the sites along the PMP that interact with the
binding factor would function as PMP targeting signals.
PMPs with multiple membrane-spanning domains would
be expected to have multiple interaction sites for the PMP
binding factor and would therefore be expected to contain
multiple nonoverlapping targeting signals.
Although this speculative model remains to be tested, it
is interesting to consider known proteins that might fulfill
the role of the proposed PMP binding factor. Molecular
chaperones are clear candidates since they are known to
mask hydrophobic domains and prevent protein aggrega-
tion. In addition to Hsp70 and Hsp40 molecules that have
been implicated in peroxisome biogenesis, a recent study
has suggested that the multicomponent cytosolic ring
chaperone, TriC, may interact with newly synthesized
PMPs (Pause et al., 1997). However, it is difficult to imag-
ine how these somewhat generic chaperones, which affect
proteins destined for many functions and subcellular com-
partments, would specify entry into the PMP import path-
way. Our hypothesis may make more sense if the PMP
binding factor acts in a pathway-specific manner, and one
such candidate has been identified. PEX19 is required for
Figure 7. Coimmunoprecipitation of PEX19 and the peroxiso-
mal targeting elements of PMP34. (a) Normal human fibroblasts
were transfected with a plasmid designed to express PMP34aa1–
147/13xmyc and plasmids designed to express either HA-PEX19
or HA-PTE1. Cells were lysed in hypotonic buffer, and the re-
sulting lysates were cleared by centrifugation and processed for
immunprecipitation using antibodies to the HA epitope. Immu-
noprecipitates and corresponding proportions of each lysate
were separated by SDS-PAGE and analyzed by immunoblot us-
ing anti-myc antibodies. (lane 1) Anti-HA immunprecipitate
from lysate of cells expressing PMP34aa1–147/13xmyc and HA-
PEX19; (lane 2) anti-HA immunoprecipitate from cells express-
ing PMP34aa1–147/13xmyc and HA-PTE1; (lane 3) lysate of cells
expressing PMP34aa1–147/13xmyc and HA-PEX19; (lane 4) ly-
sate of cells expressing PMP34aa1–147/13xmyc and HA-PTE1.
(b) Fibroblasts were transfected with a plasmid designed to ex-
press PMP34aa244–307/3xmyc and plasmids designed to express
either HA-PEX19 or HA-PTE1. Cell lysis, immunoprecipitation,
and immunoblot were performed as in panel a. (lane 1) Anti-HA
immunprecipitate from lysate of cells expressing PMP34aa244–
307/3xmyc and HA-PEX19; (lane 2) anti-HA immunoprecipitate
from lysate of cells expressing PMP34aa244–307/3xmyc and HA-
PTE1; (lane 3) lysate of cells expressing PMP34aa244–307/3xmyc
and HA-PEX19; (lane 4) lysate of cells expressing PMP34aa244–
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PMP import, interacts with all known human PMPs, and
interacts with the PMP targeting signals of PMP70 and
PEX11  (Sacksteder et al., 2000). We have shown here
that PEX19 also interacts with the two targeting signals of
PMP34. Mislocalization of PEX19 to the nucleus results in
the nuclear accumulation of proteins containing either
PMP34 targeting signal. Also, we detected coimmunopre-
cipitation of PEX19 and the PMP34 targeting signals. A
previous study of PEX19–PMP interactions in the yeast P.
pastoris concluded that PEX19 does not interact with
PMPs before their import and therefore could not act as
the proposed PMP binding factor (Snyder et al., 2000).
However, in this study, we established that PEX19 does
interact with PMPs in the cytosol, since our coimmunopre-
cipitation experiments were performed with cytosolic ly-
sates that lack peroxisomal membranes. Although our re-
sults are consistent with the hypothesis that PEX19 may
function as a chaperone and/or import receptor for newly
synthesized PMPs, a direct test of this hypothesis remains
to be performed.
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